Irina Tsibulak

8PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.

|Dec 22, 2025
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.

Christoph Ebner, Ricarda Purtscheller, Barin Feroz

|Dec 11, 2025
The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of TP53-Mutated High-Grade Serous Ovarian Cancer.

Katharina Steger, Heidelinde Fiegl, Katja Rungger

|Aug 08, 2023
Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer.

Irina Tsibulak, Christina Fotopoulou

|Feb 11, 2022
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer.

Irina Tsibulak, Stephan Polterauer, Alexander Reinthaller

|Sep 24, 2021
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective.

Katharina Knoll, Elisabeth Reiser, Katharina Leitner

Pageof 2

Frequent Collaborators

4 joint publications

Katharina Leitner

4 joint publications

Christoph Ebner

3 joint publications

Christian Marth

3 joint publications

Barin Feroz